Lung Cancer Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.
Claire Verschraegen, MD, comments on a phase 2 study examining the use of chemotherapy with durvalumab in patients with pleural mesothelioma.View More
Dr Bauml discusses how he and his lung cancer patients have adapted during this unprecedented time.View More
Shirish Gadgeel, MBBS, discusses updated findings from the KEYNOTE-189 clinical trial.View More
Kristin Higgins, MD, Winship Cancer Institute, shares how the treatment of patients with lung cancer has been impacted by the COVID-19 pandemic.View More
Joshua Bauml, MD, shares first-hand insight on the management of lung cancer during the COVID-19 pandemic.View More